BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/26/2024 8:53:40 AM | Browse: 193 | Download: 926
 |
Received |
|
2024-01-25 21:32 |
 |
Peer-Review Started |
|
2024-01-25 21:32 |
 |
First Decision by Editorial Office Director |
|
2024-02-01 21:53 |
 |
Return for Revision |
|
2024-02-01 21:53 |
 |
Revised |
|
2024-02-21 11:59 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2024-03-28 06:50 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2024-03-28 08:48 |
 |
Articles in Press |
|
2024-03-28 08:48 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-04-21 08:54 |
 |
Publish the Manuscript Online |
|
2024-04-26 08:53 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Chitin-glucan improves important pathophysiological features of irritable bowel syndrome
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Caroline Valibouze, Caroline Dubuquoy, Philippe Chavatte, Michaël Genin, Veronique Maquet, Salvatore Modica, Pierre Desreumaux and Christel Rousseaux |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Service Public de Wallonie (SPW-EER, convention 8588, Belgium) |
|
|
| Corresponding Author |
Christel Rousseaux, PhD, Researcher, Intestinal Biotech Development, Faculté de Médicine, Pole Recherche Amphi JK, Bd du Pr Jules Leclercq, Lille 59045, France. crousseaux@ibd-biotech.com |
| Key Words |
Chitin-glucan; Irritable bowel syndrome; Abdominal pain; Inflammation; Intestinal barrier; Molecular modelling; Microbial cell walls chelation |
| Core Tip |
Currently available irritable bowel syndrome (IBS) treatments are often inadequate. Chitin-glucan is a novel, well-tolerated, non-digestible prebiotic considered a safe food ingredient by the European Food Safety Authority. This study suggests new capacities of chitin-glucan to target most pathophysiological mechanisms of IBS and its therapeutic potential as a promising new generation of prebiotics for patients with IBS or IBS-like symptoms. |
| Publish Date |
2024-04-26 08:53 |
| Citation |
Valibouze C, Dubuquoy C, Chavatte P, Genin M, Maquet V, Modica S, Desreumaux P, Rousseaux C. Chitin-glucan improves important pathophysiological features of irritable bowel syndrome. World J Gastroenterol 2024; 30(16): 2258-2271 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i16/2258.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i16.2258 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.